Indefinite Delivery Contract SPE2DM20D9210

The federal contract IDV award, SPE2DM20D9210, is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued up to $4,999,999, has an ultimate completion date of August 27, 2027. It enables the rapid procurement of a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515 to support military treatment facilities and Department of Defense customers in DLA Region 1. This includes surgical dressings, drugs, biologicals, and other medical consumables. Cardinal Health 200, LLC is a major supplier of medical and pharmaceutical products to the U.S. federal government, leveraging its parent company's extensive experience in healthcare distribution and manufacturing to meet the complex needs of government customers. The company holds several significant federal contract IDVs and has been awarded multiple delivery orders against various IDCs, demonstrating its critical role in supporting the federal government's healthcare supply chain.

In addition to the DLA IDC, Cardinal Health, Inc., the parent company of Cardinal Health 200, LLC, holds a substantial single-award IDC with the Department of Veterans Affairs (VA) valued at $773,677.24 for the provision of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system. The company's subsidiary, The Harvard Drug Group, L.L.C., has also secured a single-award IDC valued at $10,056,938.10 with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets. These flexible contracting vehicles demonstrate Cardinal Health's ability to manage large-scale, multi-agency pharmaceutical supply agreements and deliver essential medical products efficiently and at scale to meet the ongoing needs of military and civilian healthcare providers.